Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults

Hum Brain Mapp. 2022 Oct 1;43(14):4225-4238. doi: 10.1002/hbm.25949. Epub 2022 Jun 7.

Abstract

Stimulants like methylphenidate, modafinil, and caffeine have repeatedly shown to enhance cognitive processes such as attention and memory. However, brain-functional mechanisms underlying such cognitive enhancing effects of stimulants are still poorly characterized. Here, we utilized behavioral and resting-state fMRI data from a double-blind randomized placebocontrolled study of methylphenidate, modafinil, and caffeine in 48 healthy male adults. The results show that performance in different memory tasks is enhanced, and functional connectivity (FC) specifically between the frontoparietal network (FPN) and default mode network (DMN) is modulated by the stimulants in comparison to placebo. Decreased negative connectivity between right prefrontal and medial parietal but also between medial temporal lobe and visual brain regions predicted stimulant-induced latent memory enhancement. We discuss dopamine's role in attention and memory as well as its ability to modulate FC between large-scale neural networks (e.g., FPN and DMN) as a potential cognitive enhancement mechanism.

Keywords: caffeine; memory; methylphenidate; modafinil; neuroenhancement; neuroimaging; resting state functional connectivity.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain / diagnostic imaging
  • Brain Mapping / methods
  • Caffeine / pharmacology
  • Central Nervous System Stimulants* / pharmacology
  • Cognition
  • Double-Blind Method
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Methylphenidate* / pharmacology
  • Modafinil / pharmacology
  • Neural Pathways / diagnostic imaging

Substances

  • Central Nervous System Stimulants
  • Methylphenidate
  • Caffeine
  • Modafinil